Blood that has been grown in a laboratory has been given to people in a world-first clinical trial, UK researchers say.
Tiny amounts – equivalent to a couple of spoonfuls – are being tested to see how it performs inside the body.
While the bulk of blood transfusions will still rely on donations, the goal is to manufacture vital, but ultra-rare, blood groups that are hard to get hold of.
These are necessary for people who depend on regular blood transfusions for conditions such as sickle cell anaemia
Please subscribe HERE http://bit.ly/1rbfUog
#Medicine #Science #BBCNews